2024 UK Therapeutic Drug Monitoring (TDM) Market

2024 UK Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new 247-page report from provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report is available by section, and can be customized to specific information needs and budget.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.

During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 247 pages and 17 tables


Introduction
Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
1. Overview
2. Amikacin
3. Apixaban
4. Argatroban
5. Betrixaban
6. Carbamazepine
7. Cyclosporin
8. Dabigatran
9. Digoxin
10. Edoxaban
11. Everolimus
12. Fluindione
13. Gentamicin
14. Levetiracetam
15. Lithium
16. Methotrexate
17. NAPA/Procainamide
18. Phenobarbital
19. Phenytoin
20. Quinidine
21. Rivaroxaban
22. Sirolimus
23. Tacrolimus
24. Theophylline
25. Tobramycin
26. Topirimate
27. Valproic Acid
28. Vancomycin
29. Warfarin
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers

C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako

List Of Tables

Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Tests
Major Companies Developing or Marketing
Biosensors for Genetic Disease Testing
U.K., Laboratories Performing TDM
Tests By Market Segment
U.K., Hospital Laboratories Performing
TDM Tests By Bed Size
U.K., Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
U.K., TDM Test Volume Forecast
By Market Segment
U.K., Hospital Laboratories, TDM
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
U.K., TDM Reagent Market Forecast
By Market Segment

U.K., Hospital Laboratories, TDM
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares

2024 U.S. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

2024 U.S. Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 997 pages and 87

USD 3750 View Report

2024 U.K. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

2024 U.K. Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 886 pages and 67

USD 3500 View Report

2024 UK Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities

2024 UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 527 pages

USD 3450 View Report

2024 UK Hospital Microbiology Analyzers and Consumables Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities

2024 UK Hospital Microbiology Analyzers and Consumables for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains

USD 3450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available